Show simple item record

dc.contributor.authorBova, Carol A.
dc.contributor.authorFennie, Kristopher P.
dc.contributor.authorKnafl, George J.
dc.contributor.authorDieckhaus, Kevin D.
dc.contributor.authorWatrous, Edith
dc.contributor.authorWilliams, Ann B.
dc.date2022-08-11T08:09:04.000
dc.date.accessioned2022-08-23T16:16:58Z
dc.date.available2022-08-23T16:16:58Z
dc.date.issued2005-04-07
dc.date.submitted2008-06-16
dc.identifier.citationAIDS Behav. 2005 Mar;9(1):103-10. <a href="http://dx.doi.org/10.1007/s10461-005-1685-0">Link to article on publisher's site</a>
dc.identifier.issn1090-7165 (Print)
dc.identifier.doi10.1007/s10461-005-1685-0
dc.identifier.pmid15812617
dc.identifier.urihttp://hdl.handle.net/20.500.14038/34448
dc.description.abstractThe purpose of this paper is to describe electronic monitoring device (EMD) (e.g., MEMS caps) use among HIV-infected adults enrolled in a randomized clinical trial and to make explicit some of the benefits and caveats of using electronic monitoring device technology. This is a descriptive, exploratory study of EMD use among 128 HIV-infected adults treated with at least three antiretroviral agents. Thirty-six percent of the sample admitted that they did not use the EMD consistently. Forty-one percent of the subjects reported taking out more than one dose at a time and 26% reported opening the EMD but not taking the medication. Special subject-related issues accounted for only a small percentage of all reported problems with EMD use (e.g., transient housing, incarceration, substance abuse relapse and drug treatment). Results of this study suggest that EMDs may underestimate antiretroviral adherence among HIV-infected adults. Recommendations for improving EMD data quality are presented.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15812617&dopt=Abstract ">Link to article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1007/s10461-005-1685-0
dc.subjectAdult
dc.subjectAnti-HIV Agents
dc.subjectDrug Monitoring
dc.subjectDrug Packaging
dc.subjectDrug Therapy, Combination
dc.subjectFemale
dc.subjectHIV Infections
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectPatient Compliance
dc.subjectRisk Factors
dc.subjectSocioeconomic Factors
dc.subjectTreatment Outcome
dc.subjectNursing
dc.subjectPublic Health and Community Nursing
dc.titleUse of electronic monitoring devices to measure antiretroviral adherence: practical considerations
dc.typeArticle
dc.source.journaltitleAIDS and behavior
dc.source.volume9
dc.source.issue1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsn_pp/12
dc.identifier.contextkey531227
html.description.abstract<p>The purpose of this paper is to describe electronic monitoring device (EMD) (e.g., MEMS caps) use among HIV-infected adults enrolled in a randomized clinical trial and to make explicit some of the benefits and caveats of using electronic monitoring device technology. This is a descriptive, exploratory study of EMD use among 128 HIV-infected adults treated with at least three antiretroviral agents. Thirty-six percent of the sample admitted that they did not use the EMD consistently. Forty-one percent of the subjects reported taking out more than one dose at a time and 26% reported opening the EMD but not taking the medication. Special subject-related issues accounted for only a small percentage of all reported problems with EMD use (e.g., transient housing, incarceration, substance abuse relapse and drug treatment). Results of this study suggest that EMDs may underestimate antiretroviral adherence among HIV-infected adults. Recommendations for improving EMD data quality are presented.</p>
dc.identifier.submissionpathgsn_pp/12
dc.contributor.departmentCenter for Infectious Disease and Vaccine Research
dc.contributor.departmentGraduate School of Nursing
dc.source.pages103-10


This item appears in the following Collection(s)

Show simple item record